Eyal C. Attar, SVP, Chief Medical Officer at Aprea Therapeutics, Inc. (APRE), sold 31,936 shares at $4.68 ($149K) on 2021-09-16, disclosed to the SEC on 2021-09-20.
Open-market sale of $149k APRE by SVP, Chief Medical Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $4.68 | 15,968 | $75K | 50.0% |
| 2 | $4.68 | 15,968 | $75K | 50.0% |
| Total | $4.68 avg | 31,936 | $149K | 100% |
| Filing → |
| VOR | SELL | 2024-12-31 | $13K | — | Filing → |
| VOR | SELL | 2024-06-04 | $20K | — | Filing → |
| APRE | SELL | 2022-03-01 | $62K | — | Filing → |